5 January 2015 - Deborah Wilkes
Archived
GlaxoSmithKline's shareholders have approved the company's proposed three-part interconditional transaction with Novartis, which will lead to the formation of a global consumer healthcare joint venture between the two companies.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.